APIS Oncology Product Portfolio

Innovative Solutions for Oncology; Advanced Assays with Precise Results

APIS ESR1 dPCR Kit

  • Wide target coverage: detects 11 ESR1 mutations

  • High sensitivity & specificity: detected at ≤ 0.1% MAF, with no WT detection

  • Instrument agnostic: compatible with most digital PCR systems

APIS PIK3CA Mutations Kit

  • Streamlined workflow: detects > 95% of actionable PIK3CA mutations

  • High sensitivity: mutations detected at ≤ 0.5% MAF

  • Multiple sample types: FFPE tumour tissue or plasma (cfDNA)

NEW APIS ESR1 qPCR Kit

  • Wide target coverage – designed to cover 11 ESR1 mutations

  • High sensitivity – all mutations are detected at ≤ 0.5% MAF

  • Instrument agnostic – compatible with a variety of real-time PCR instruments

  • Simultaneous ESR1 & PIK3CA testing – when combined with the APIS PIK3CA qPCR Kit in one run

APIS Breast Cancer Subtyping Kit

  • Novel RT-qPCR assay for detecting HER2, ER, PR & Ki67 mRNA expression with high precision and reproducibility

  • Single HER2 resolution method, without the need for reflex testing

  • Novel four-gene signature for measuring proliferation, supporting use of Ki67 alone

  • Automated results interpretation with APIS software

  • Opportunity to enhance HER2 stratification

APIS MET Alterations Kit

  • The new RT-qPCR assay for simultaneously detecting both MET exon 14 skipping mutation and MET gene overexpression

  • Simple protocol compatible with most qPCR cyclers

  • Designed for tumour tissue (FFPE) or liquid biopsy